![Anders Sandberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Anders Sandberg is the founder of Alzinova AB, where he currently holds the title of Chief Scientific Officer since 2015.
He also worked as a Principal at MIVAC Development AB. Dr. Sandberg completed his undergraduate and doctorate degrees at the University of Gothenburg.
Actieve functies van Anders Sandberg
| Bedrijven | Functie | Begin |
|---|---|---|
| ALZINOVA AB | Oprichter | 17-08-2011 |
Eerdere bekende functies van Anders Sandberg
| Bedrijven | Functie | Einde |
|---|---|---|
MIVAC Development AB
 MIVAC Development AB BiotechnologyHealth Technology Operates as a biopharmaceutical company which focuses on developing and commercializing novel treatments of autoimmune diseases | Corporate Officer/Principal | - |
Opleiding van Anders Sandberg
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
5
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
University of Gothenburg
 University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIVAC Development AB
MIVAC Development AB BiotechnologyHealth Technology Operates as a biopharmaceutical company which focuses on developing and commercializing novel treatments of autoimmune diseases | Health Technology |
Alzinova AB
 Alzinova AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides treatment for Alzheimer’s disease | Health Technology |
